Immunological priming with synthetic peptides of foot-and-mouth disease virus

Area of Science:

• Immunology
• Virology
• Vaccine Development

Background:

• Foot-and-mouth disease virus (FMDV) poses a significant threat to livestock.
• Developing effective FMDV vaccines is crucial for global animal health.
• Understanding immune responses to viral peptides is key for vaccine design.

Purpose of the Study:

• To investigate the immunogenic potential of a synthetic peptide from FMDV VP1 protein.
• To determine the requirements for priming an FMDV serotype-specific neutralizing antibody response.
• To explore the role of the peptide in initiating T-helper cell responses.

Main Methods:

• Guinea pigs were immunized with a synthetic peptide (amino acids 141-160) from FMDV VP1, coupled to keyhole limpet haemocyanin (KLH).
• Sub-immunizing doses were administered with varying intervals (optimal 42 days) and adjuvants.
• Immune responses were assessed by measuring neutralizing antibody titers.
• Alternative carriers (unmodified peptide, peptide coupled to tetanus toxoid, peptide in liposomes) were tested for priming efficacy.

Main Results:

• A sub-immunizing dose of 141-160KLH primed guinea pigs for a serotype-specific neutralizing antibody response upon secondary challenge.
• Optimal priming required a 42-day interval and an adjuvant.
• The carrier molecule did not restrict the secondary response; uncoupled peptide or peptide coupled to tetanus toxoid could also boost the response.
• Uncoupled peptide incorporated into liposomes also induced a priming effect.

Conclusions:

• The 141-160 peptide of FMDV contains a critical neutralizing antibody site.
• This peptide can independently initiate T-helper cell responses, suggesting its potential as a self-adjuvanting vaccine component.
• These findings have implications for developing novel FMDV subunit vaccines.